HYPHEN BioMed Hemostasis & Coagulation Reagents —
Anti-Xa, DOAC & Thrombophilia Testing
Aniara Diagnostica is the specialist North American distributor for hemostasis, coagulation, and genotoxicity reagents — serving hospital coagulation laboratories, academic research institutions, and industrial QC labs across the United States, Canada, and the Nordic regions.
We are the exclusive North American distributor for HYPHEN BioMed’s BIOPHEN™ and HEMOCLOT™ product families, including anti-Xa and anti-IIa chromogenic assays, DOAC monitoring reagents for dabigatran, rivaroxaban, apixaban, and edoxaban, thrombophilia testing kits, platelet aggregation reagents, and the ZYMUTEST™ HIA IgG — the only 510(k)-cleared IgG-specific HIT antibody ELISA in the US. BIOPHEN™ chromogenic substrates are validated equivalents to the Chromogenix S-series — including S-2238, S-2732, S-2765, and S-2366 — for laboratories seeking an alternative source.
DOAC-Remove activated charcoal tablets and DP-Filter from 5-Diagnostics are the only validated systems for removing DOACs from plasma specimens, enabling accurate coagulation testing in anticoagulated patients. Our catalog also includes 5-Diagnostics pharmacopoeial heparin potency kits, Medicago buffer reagents and lectins, and Xenometrix Ames mutagenicity and genotoxicity test systems.
Family-owned since 2004, based in West Chester, Ohio — backed by a technical team who specialize in coagulation science.
